Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 189.19B | 208.35B | 241.39B | 157.74B | 105.94B |
Gross Profit | 30.24B | 64.06B | 55.10B | 22.86B | 10.18B |
EBITDA | 27.98B | 43.50B | 59.47B | 32.55B | 14.54B |
Net Income | 381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | |||||
Total Assets | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
Cash, Cash Equivalents and Short-Term Investments | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B |
Total Debt | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
Total Liabilities | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
Stockholders Equity | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | |||||
Free Cash Flow | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
Operating Cash Flow | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
Investing Cash Flow | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
Financing Cash Flow | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £1.54B | 14.21 | 7.92% | 3.71% | 118.04% | 65.66% | |
75 Outperform | £156.29B | 15.49 | 7.54% | 4.04% | -8.55% | -22.62% | |
74 Outperform | £1.70B | 11.52 | 17.50% | 5.68% | -9.80% | -1.98% | |
72 Outperform | £65.63B | ― | 5.36% | ― | ― | ||
70 Neutral | £4.02B | 21.62 | -11.32% | 7.35% | 123.03% | ― | |
67 Neutral | £2.91B | 15.84 | -5.65% | 14.89% | 1.04% | -156.59% | |
56 Neutral | C$4.17B | 2.02 | 16.25% | 5.62% | 10.63% | -50.60% |